Slow-k and Cholangitis - a phase IV clinical study of FDA data

Summary:

Cholangitis is reported as a side effect among people who take Slow-k (potassium chloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Pancreatin, and have Constipation.

The phase IV clinical study analyzes which people have Cholangitis when taking Slow-k. It is created by eHealthMe based on reports of 3,640 people who have side effects when taking Slow-k from the FDA, and is updated regularly.

What is Slow-k?

Slow-k has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 3,683 Slow-k users. Check the latest studies of Slow-k.

What is Cholangitis?

Cholangitis (infection of the bile duct) is found to be associated with 655 drugs and 749 conditions by eHealthMe. Check the latest studies of Cholangitis.

On Aug, 05, 2026

3,640 people reported to have side effects when taking Slow-k.
Among them, 22 people (0.6%) have Cholangitis.

Among these 22 people:

How long have people been on Slow-k when they have Cholangitis? *

What is the gender of people who have Cholangitis when taking Slow-k? *

female: 54.55 %
male: 45.45 %

What is the age of people who have Cholangitis when taking Slow-k? *

What are other drugs people take besides Slow-k? *

What are other side effects people have besides Cholangitis? *

Malignant Neoplasm Progression (cancer tumour came back): 19 people, 86.36%
Gastrointestinal Hypomotility (less activity of the intestinal tract): 10 people, 45.45%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 10 people, 45.45%
Cardiac Function Test Abnormal: 10 people, 45.45%
Cardiomyopathy (weakening of the heart muscle): 10 people, 45.45%
Chills (felling of cold): 10 people, 45.45%
Oropharyngeal Pain: 10 people, 45.45%
Fever: 10 people, 45.45%
Headache (pain in head): 10 people, 45.45%
Inflammation: 10 people, 45.45%

What are the existing conditions these people have? *

Constipation: 19 people, 86.36%
Fever: 10 people, 45.45%
Allergic Rhinitis: 10 people, 45.45%
Reflux Oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus): 10 people, 45.45%
Rashes (redness): 10 people, 45.45%
Pancreatitis Chronic (chronic inflammation of pancreas): 10 people, 45.45%
Pancreatic Neuroendocrine Tumor: 10 people, 45.45%
Insomnia (sleeplessness): 10 people, 45.45%
Cheilitis (infection of lips): 10 people, 45.45%
Hepatic Function Abnormal: 10 people, 45.45%

* Approximation only. Some reports may have incomplete information.

Do you take Slow-k and have Cholangitis?

- Check whether Cholangitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Slow-k:

Slow-k (3,683 reports)

Cholangitis treatments and more:

Cholangitis (7,720 reports)

Browse all side effects of Slow-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cholangitis:

Cholangitis (655 drugs)

Browse all the conditions that are associated with Cholangitis:

Cholangitis (749 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on potassium chloride (the active ingredients of Slow-k) and Slow-k (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.